Intra-Cellular Therapies, Inc. - 46116X101

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q1 2025 · Q4 2024
Value (USD)
Total reported value ($000)
$10.72B
QoQ value delta ($000)
+$3.376B (+45.95%)
Implied price effect (QoQ)
+57.95%
Shares
Total shares
81,289,093
QoQ shares delta
-6,682,781 (-7.6%)
Total shares held by funds (by quarter)

Top holders (Q1 2025)

Top 25 only Full list
Early Q4 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 1,255,874 9,519,968 0.02%
BlackRock, Inc. 1,154,955 8,754,966 0.02%
Pentwater Capital Management LP 684,664 5,190,000 5.75%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 459,748 3,485,058 131.68%
FARALLON CAPITAL MANAGEMENT LLC 403,015 3,055,000 147.16%
FMR LLC 351,206 2,662,273 0.02%
LMR Partners LLP 303,974 2,304,234 2.84%
CITADEL ADVISORS LLC 301,164 2,282,931 0.06%
BALYASNY ASSET MANAGEMENT L.P. 297,863 2,257,912 0.49%
Deep Track Capital, LP 263,840 2,000,000 8.54%
GEODE CAPITAL MANAGEMENT, LLC 241,741 1,831,951 0.02%
BANK OF AMERICA CORP /DE/ 239,472 1,815,287 0.02%
STATE STREET CORP 234,991 1,781,316 0.01%
UBS Group AG 216,856 1,643,845 0.04%
Weiss Asset Management LP 216,352 1,640,029 550.57%
GOLDMAN SACHS GROUP INC 194,418 1,473,764 0.03%
MORGAN STANLEY 185,136 1,403,399 0.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 144,285 1,093,738 0.53%
Qube Research & Technologies Ltd 122,861 931,330 0.14%
D. E. Shaw & Co., Inc. 121,868 923,809 0.11%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 118,155 895,664 0.02%
MILLENNIUM MANAGEMENT LLC 115,268 873,773 0.06%
PERCEPTIVE ADVISORS LLC 103,736 786,358 3.66%
JPMORGAN CHASE & CO 100,258 759,991 0.01%
WHITEBOX ADVISORS LLC 95,655 725,101 2.47%